Fast-food chain Wendy’s (NASDAQ:WEN) reported Q4 CY2025 results exceeding the market’s revenue expectations, but sales fell by 5.5% year on year to $543 million. Its non-GAAP profit of $0.16 per share was 10.4% above analysts’ consensus estimates.

Biotechnology company Moderna (NASDAQ:MRNA) beat Wall Street’s revenue expectations in Q4 CY2025, but sales fell by 29.8% year on year to $678 million. Its GAAP loss of $2.11 per share was 18.9% above analysts’ consensus estimates.

Despite PPG Industries' outperformance relative to the SPX over the past year, Wall Street analysts maintain a cautiously optimistic outlook about the stock’s prospects.

The British-born chief executive of US bank Citi has seen her pay rise to $42m (£31m), elevating her into the ranks of the best-paid leaders on Wall Street.

On this Friday the 13th, I didn’t have to try hard to come up with a scary SaaS story for you.

The price action has been stark: TripAdvisor Inc. has plunged 29% this year, sinking to an all-time low this week after its earnings disappointed. Booking Holdings Inc. and Amadeus IT Group SA have each lost 22% this year. By contrast, Marriott Internat

But analysts on Wall Street this morning are suggesting that the selloff may be overdone.

Executives at Apollo, Ares, Blackstone, KKR and other private capital firms are having trouble convincing stock market investors that their portfolios are safe from the effects of a selloff battering the software sector due to fears that artificial intell

Money market account rates vary widely. So which banks are offering the best money market account rates today? Find out here.

U.S. stock and bond markets are closed Monday, Feb. 16, to mark Presidents' Day, which is when the birthday of former President George Washington is observed.

Masco has trailed the broader market over the past year; however, analysts maintain a cautiously constructive stance on the stock’s forward outlook.

Cadence Design Systems has underperformed the S&P 500 Index over the past year, but analysts are highly optimistic about the stock’s prospects.

Hartford Insurance has outperformed the broader market over the past year, and analysts remain moderately positive on the stock’s outlook.

Textron has outpaced the broader market over the past year; however, analysts remain cautiously optimistic about its forward prospects.

Brown-Forman has materially underperformed the broader market over the past 52 weeks, and Wall Street analysts remain cautious on the stock’s forward outlook.